What is the most appropriate indication to present in sales materials when consulting with a regulatory professional about using the same materials in multiple countries?

When consulting with a regulatory professional about using sales materials in multiple countries, presenting "No indications" is appropriate because it reflects the complex nature of pharmaceutical advertising regulations that vary significantly across different jurisdictions. Many countries have strict rules concerning promotional materials, particularly regarding the inclusion of drug indications.

By stating "No indications," the sales materials can focus on broader aspects that are generally acceptable across various markets without running afoul of specific local regulations. This approach minimizes the risk of non-compliance by avoiding the need to tailor the information based on varying indications that might be legal in one country but not in another.

This strategy allows for a more universally acceptable set of sales materials that can be utilized effectively while respecting international regulatory differences. The emphasis should be on ensuring that the communication adheres to the most stringent requirements, which is often a best practice in the global pharmaceutical industry.